QuidelOrtho Corp

The active Lockout Rally under Stage 2 advancing confirms strong forced-demand dynamics, and price remains tightly above rising short-term EMAs despite overbought conditions. Medium-term bullish bias is supported by higher highs and higher lows on expanding volume, while the long-term downtrend below the 200 SMA warrants caution. Given the shallow pullback into the EMA confluence, continuation participation is recommended now.

• ↑Divestiture of point-of-care unit for ~$1.5B to reduce 1.09x net debt leverage
• ↑Delivered $140M cost savings; adjusted EBITDA margin at 25%
• ↓Q1 revenue at $620M, down on softer respiratory season versus last year